The Role of Lp(a) in ASCVD
Lipoprotein (a) was first described by Kåre Berg in 1963; half a century after its discovery, it is well established that increased levels of Lp(a) confer an increased risk for CVD.
Antibody Testing with Biorex Diagnostics
As the Covid-19 pandemic continues to unfold there is a growing interest in antibody testing and its benefits. Antibody tests are used to detect the presence of antibodies to SARS-CoV-2 to determine if it’s likely that an individual has had
Dental Practices using the Biorex Antibody test
General dental practitioners have been limited to providing non-AGPs to non-COVID-19 patients with an urgent dental care need. Throughout this crisis period, many such patients have continued to receive face to face care in general dental practices. This has been
Bleeding Disorders Associated with COVID-19
Biorex Diagnostics would like to advise of the guidelines on bleeding disorders associated with COVID-19 recently released by the International Society of Thrombosis and Haemostasis (ISTH). Many severely ill patients initially present with single organ failure (i.e. respiratory insufficiency) but